Multivitamins and Foundational Wellness Because GLP-1 users may eat less overall, some people ask whether they should add a multivitamin
The question behind the question is usually: "How much longer will I be able to get compounded semaglutide at this price?" The pattern we see: patients conflate three separate timelines: Patent expiration (2031-2033 for the formulations that matter) FDA shortage list removal (expected late 2026 to Q1 2027) Generic market entry (2027 for oral, 2031-2032 for injectable, assuming no patent challenges) The timeline that affects current compounded access is number 2, not number 1
Medical supervision ensures: Correct dosing protocols Monitoring of metabolic markers Integration with nutrition and fitness plans Sustainable, health-focused outcomes This level of oversight distinguishes medically guided care from unsupervised weight loss trends
Second, we excluded patients with prior suicidal ideation or suicide attempts to reduce confounding, but this prevented us from evaluating whether tirzepatide could reduce suicidality in that high-risk subset
Concerned about the whitening drips side effects